Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec : a population-based utilization review.
about
Risk factors for asthma-related healthcare use: longitudinal analysis using the NHI claims database in a Korean asthma cohortControlling asthma by training of Capnometry-Assisted Hypoventilation (CATCH) vs slow breathing: a randomized controlled trialFactors associated with the appropriate use of asthma drugs.Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.Use of inhaled corticosteroids following discharge from an emergency department for an acute exacerbation of asthma.Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma.Pattern of asthma medication use among children from a large urban center in Brazil.Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD.Towards Excellence in Asthma Management: final report of an eight-year program aimed at reducing care gaps in asthma management in Quebec.Factors associated with adherence to asthma treatment with inhaled corticosteroids: A cross-sectional exploratory study.Effect of feedback letters to physicians and pharmacists on the appropriate use of medication in the treatment of asthma.Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use.
P2860
Q28544969-8AEF4ADE-ED46-4646-90A4-315255126E54Q30596846-76E16C58-F8DE-48FC-BE58-66ECA2541337Q34884943-784428FF-29EE-4EB8-9945-7DA69E495F99Q34888769-E6DAC69A-9761-4E52-9457-37032B1DAA0AQ35536288-B4FB7E04-5232-49F9-8FE7-C93D192DE512Q35588329-7ED0A67A-FBC4-4C7F-99A8-CD0AFCB67CBDQ36150135-63E43C1F-60E5-4ADA-B7AF-A74173B2F298Q36428054-BD59F809-931A-439E-B187-F95B717FA301Q37279823-2E71B062-D0B9-4CA6-AF16-E45AC5150B1BQ38377220-9A47B26A-233C-4ACD-9574-7DB057BD5534Q43585151-8BFC98A7-165C-4ADA-9F5B-FF386A2191D1Q51754232-6EB5C447-A169-460F-9415-25963F58FB49
P2860
Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec : a population-based utilization review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Ambulatory use of inhaled beta
@nl
Ambulatory use of inhaled beta ...... tion-based utilization review.
@ast
Ambulatory use of inhaled beta ...... tion-based utilization review.
@en
type
label
Ambulatory use of inhaled beta
@nl
Ambulatory use of inhaled beta ...... tion-based utilization review.
@ast
Ambulatory use of inhaled beta ...... tion-based utilization review.
@en
prefLabel
Ambulatory use of inhaled beta
@nl
Ambulatory use of inhaled beta ...... tion-based utilization review.
@ast
Ambulatory use of inhaled beta ...... tion-based utilization review.
@en
P2093
P356
P1433
P1476
Ambulatory use of inhaled beta ...... ation-based utilization review
@en
P2093
Comité de revue de l'utilisation des médicaments
J Bouchard
L P Boulet
P304
P356
10.1378/CHEST.119.5.1316
P407
P577
2001-05-01T00:00:00Z